9
Oct
2025
Too Many Life Sciences Boards Are Shirking Responsibilities
There is a persistent myth in life sciences that once a company transitions from a scrappy startup into a more mature company, its board will naturally evolve to meet those new, more complex challenges. The reality is that these boards all too often fail to keep pace with their organizations. Those gaps leave management teams without the strategic guidance and... Read More
6
Oct
2025
Silicon Valley: Yes, AI Does Enhances Productivity — In The Right Hands & Context
Outside the glare of hyperbolic headlines, organizations of all sizes – including most in healthcare – are urgently trying to figure out how AI will fit into their workflows and business plans. Perhaps the most interesting recent discussion I’ve heard on this subject involved a trio of Andreessen-Horowitz (a16z) partners — Erik Torenberg, Martin Casado, and Steven Sinofsky — who were... Read More
6
Oct
2025
An Outstanding ‘Mini’ Traverse of Katahdin for Damon Runyon Cancer Research
The Timmerman Traverse for Damon Runyon Cancer Research Foundation had a spectacular experience on Mt. Katahdin in Maine on Saturday. Weather was glorious. Fall colors were vibrant. The team was fit and mentally ready for rocky, rugged terrain. They got a rich outdoor experience with a steep rock scramble on Cathedral Path, then crossing Katahdin’s famous Knife Edge ridge. This... Read More
6
Oct
2025
“Food Intelligence”: Make Healthy the Default — In Public Spaces and Private Kitchens
While “nutrition science” often seems to cry out for air quotes around “science,” we are fortunate now to have a new book on the topic written by one of the most thoughtful and deliberate nutrition researchers of the modern age: Kevin Hall. Hall has consistently steered a course of thoughtful rigor, leading a succession of highly impactful studies at the... Read More
6
Oct
2025
Arbor Takes Next-Gen Gene Editing into the Clinic, Secures Chiesi Partnership
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
5
Oct
2025
Consumer Health’s Digital Convergence – And What’s Still Missing
Consumers are taking increased ownership of their health. As Laura Landro recently described in the Wall Street Journal, this trend is driven in part by necessity — specifically by “a shortage of doctors, long wait times for appointments and an increasing prevalence of chronic diseases such as diabetes earlier in adulthood.” But our push to manage our own health is also motivated... Read More
2
Oct
2025
Pfizer Buys Metsera GLP-1s, Genmab Nabs Merus for $8B, & Sanofi Commits to VC
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
2
Oct
2025
Cartography Secures $67M for T-cell Engager for Colorectal Cancer (and a Platform, Too)
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
29
Sep
2025
A Song of Science and Hope: Bruce Levine & Mags McCarthy on The Long Run
Today’s guests on The Long Run are Bruce Levine and Mags McCarthy. Bruce is a scientist at the University of Pennsylvania Perelman School of Medicine. He’s one of the world leaders in engineering CAR-T cell therapies for cancer. Mags McCarthy is a country music star. What do these two have in common? A shared desire to sing from the rooftops... Read More
18
Sep
2025
Roche Buys 89Bio, Novartis Doubles Down on Monte Rosa, & aTyr Flames Out
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
17
Sep
2025
Predicting Leukemia Risk At Scale: Dr. Lachelle Weeks on The Long Run
Dr. Lachelle Weeks is today’s guest on The Long Run. Lachelle is a physician-scientist in the adult leukemia program at Dana-Farber Cancer Institute in Boston. She treats patients who have precursors to myeloid cancers such as acute myeloid leukemia. Her research is looking at ways to detect the early warning signs of blood cancer early, when these malignancies are most... Read More
17
Sep
2025
Arch-Backed Ollin Secures $100M For Bispecific Antibodies for Eye Diseases
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
16
Sep
2025
First CinCor, Now AllRock: Versant, Westlake Pump $50M Into PAH Startup
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
14
Sep
2025
Leveraging AI at the FDA—Product Reviews and Beyond
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
11
Sep
2025
An IPO Revival, Novartis Buys Tourmaline, & Tribute to a Biology Pioneer
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
11
Sep
2025
Can Biopharma Make AI Sing?
“… When I’m with her I’m confused Out of focus and bemused And I never know exactly where I am Unpredictable as weather She’s as flighty as a feather She’s a darling, she’s a demon, she’s a lamb… … How do you solve a problem like Maria? How do you catch a cloud and pin it down?” The lyrics, of course, are... Read More
9
Sep
2025
Next Stop: Kilimanjaro 2026 for Damon Runyon Cancer Research
The biotech industry can do amazing things when focused on an audacious goal. Like curing cancer. I’m fired up to announce the next Timmerman Traverse for Damon Runyon Cancer Research Foundation. This group of 23 biotech executives and investors are training to hike up to the summit of Kilimanjaro, the highest peak in Africa (elev. 19,341 feet), in February 2026.... Read More
5
Sep
2025
Novartis CEO Vas Narasimhan: Drawn to Analytics, Grounded Expectations for AI
Yesterday, the MS/MBA program at Harvard Business School (HBS) hosted Novartis CEO Dr. Vas Narasimhan for what proved to be a captivating and wide-ranging discussion, led by Dr. Christiana Bardon (Managing Partner of MPM BioImpact) and Professor Amitabh Chandra of HBS and the Harvard Kennedy School. Chandra co-leads the MS/MBA program together with the former head of Novartis’s early research... Read More
4
Sep
2025
Atlas Adds $400M, Kite Buys In Vivo CAR-T Company, & AbbVie Bets on Psychedelics
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
2
Sep
2025
Corsera Health, Led by Maraganore and Meanwell, Aims to Prevent Heart Disease
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.